QuantRx Biomedical Corporation Completes Final Phase of Equity Financing, Raising an Additional $3.53 Million for Aggregate Proceeds of $5.57 Million

DOYLESTOWN, PA -- (MARKET WIRE) -- March 06, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced that it has further strengthened its financial position with the completion of a private placement to certain institutional and accredited investors of 3.53 million shares of QuantRx common stock at a per share price of $1.00. As a result, the Company realized aggregate gross proceeds of approximately $3.53 million in the final financing phase.